insights_auto
Outlook: 37.8% bullish·6.1% bearish
Go to analysischevron_right
JNJ:NYSE
Johnson & Johnson
$263.81
arrow_downward
-1.46%(-3.90) 1D
$263.16
arrow_downward
-0.25% (-0.65)bedtimeAfter hours
Closed: Oct 23, 4:00:04 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for JNJ...
Open
$265.82
High
$266.02
Low
$262.40
Mkt. cap
635.07B
Avg. vol.
7.42M
Volume
5.31M
Dividend
2.03%
Quarterly dividend
$1.34
Ex-dividend date
Aug 25, 2026
P/E ratio
40.04
52-wk high
$281.07
52-wk low
$184.66
EPS
$6.59
Beta
0.21
Shares outstanding
2.41B
No. of employees
138K
Open
$265.82
High
$266.02
Low
$262.40
Mkt. cap
635.07B
Avg. vol.
7.42M
Volume
5.31M
Dividend
2.03%
Quarterly dividend
$1.34
Ex-dividend date
Aug 25, 2026
P/E ratio
40.04
52-wk high
$281.07
52-wk low
$184.66
EPS
$6.59
Beta
0.21
Shares outstanding
2.41B
No. of employees
138K
News stories
From web sources and news partners
Investing.com
·
5 hours ago
Johnson & Johnson’s prostate cancer drug shrinks tumors in early-stage trial By Reuters
MassDevice
·
15 hours ago
J&J, Smith+Nephew plans for ortho megamerger reportedly fall through
Reuters
·
17 hours ago
Smith & Nephew orthopaedics deal talks with J&J fail over CEO choice, source says
Yahoo Finance
·
1 day ago
Johnson & Johnson (JNJ) Stock Gets Fair Value Bump On Mixed Analyst Target Changes
About Johnson & Johnson
CEOJoaquin Duato
Employees138K
FoundedJan 1886
HeadquartersNew Brunswick, New Jersey, United States
SectorPharmaceutical industry
Websitejnj.com